ALK Positive Inc.

Be sure to join us this evening at 7pm ET as members of the Nuvalent, Inc. Team return to ALKtALK. Nuvalent’s Christopher D. Turner, MD, Chief Medical Officer, and Viola Zhu, MD PhD, VP of Clinical Development will present data on the Phase 1 study of NVL-655. ALK community members will be able to ask questions after the presentation. You won’t want to miss this informative ALKtALK 👉 https://lnkd.in/gkDha4Y4

Research holds the promise of a great life with ALK+ lung cancer. That's why we believe in #MoreResearchMoreLife. Tune into this ALKtALK to hear Dr Kenneth Culver MD and Suzanne H. kick off our Lung Cancer Awareness campaign. Here we discuss the advances we’ve made together and the immense opportunities that lie ahead - all thanks to research. Get informed and involved today by watching this informative and inspirational episode. Available on our YouTube channel: https://lnkd.in/eNzg3dr7. #clinicaltrials #hope #lungcancer #research #LCAM

We're #hiring a new Grant Manager in United States. Apply today or share this post with your network.

In case you missed the news, Suzanne H. joined us in August as our Executive Director. Read more about Suzanne's incredible professional and personal background and how she's a great fit to lead us in our mission to cure ALK-positive cancers. Suzanne say, "I am most inspired by our patient advocacy work; giving voice to patients and their families at every table and at every opportunity is particularly close to my heart. I am equally inspired by our unique approach to funding unbiased cancer research. Our true allegiance is to the ALK-positive patient population. We are committed to searching for and funding the most promising biomedical research regardless of who is leading it or where." Read more at: https://lnkd.in/e62madwD

Join our next ALKtALK tomorrow (Sunday, 6 Oct) at 7pm ET, as we kick off our Lung Cancer Awareness Month plans. You’ll hear from Suzanne H., our new Executive Director and Kenneth Culver MD, our Director of Research & Clinical Affairs. Our community’s involvement is vital to supporting our research ambitions. We’ll share an update on research and more about our plans. Join to be empowered and inspired. Details at: https://lnkd.in/gkDha4Y4 #LCAM #lungcancer #research #patients #hope #live

Join our next ALKtALK tomorrow (Sunday, 6 Oct) at 7pm ET, as we kick off our Lung Cancer Awareness Month plans. You’ll hear from Suzanne H., our new Executive Director and Kenneth Culver MD, our Director of Research & Clinical Affairs. Our community’s involvement is vital to supporting our research ambitions. We’ll share an update on research and more about our plans. Join to be empowered and inspired. Details at: https://lnkd.in/gkDha4Y4 #LCAM #lungcancer #research #patients #hope #live

By far, this might be one of the most fun customer events we've put on! Thanks World Wide Technology Hewlett Packard Enterprise HPE Aruba Networking and our customers for the great turnout. Congrats to our Champions. We were also able to help promote Cancer Research that benefits so many of our family and friends. Thanks Joe Koenig and Matt McAvin for sharing your journey with us and continuing to inspire so many people. Still time to donate if you wish. Team Joe - Head and Neck Cancer Research https://lnkd.in/gKTkGg2p Team Matt - ALK Positive Lung Cancer Research https://lnkd.in/g7anW5rw Doug Uthoff Blake Britton Cindy Karczewski Jacqui Dillow Mark Gross Sarah McIntyre Andrew Palumbo

Our ALK+ patient community is invited to our next ALKtALK on Sunday, September 29th at the slightly earlier time of 5pm ET. Dr. Jessica Lin will provide an update on the research and highlights from the recent IASLC #WCLC24 and #ESMO24 conferences. As usual, she'll also take questions from our ALK+ cancer community. You'll walk away informed, connected and inspired. Dial in details at: https://lnkd.in/gkDha4Y4.

Watch the replay of our recent ALKtALK w Drs Drew Moghanaki, MD, MPH & Matthew Quirk, MD, looking at the use of all forms of radiotherapy when tumors won't disappear. Lots of great topics covered, including the roles of ablation, radiotherapy & LCT for our ALK+ #lungcancer family. 📺 https://lnkd.in/eYfrJMWP #lungcancer #radiology #radiotherapy #ablation #cancer

During #WCLC24 in San Diego, Kenneth Culver MD, our Research & Clinical Affairs Director, spoke with Lung Cancers Today about how we're supporting research through our patient registry - the ALK Life Study. Ken also spoke about the importance of #biomarkertesting for all lung cancers. Be sure to watch 👉 https://lnkd.in/eG9eBZXG #lungcancer #research #patientadvocacy #registry